Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acupoint Sensitization in Inflammatory Bowel Disease: A Non-interventional Study

NCT07681895 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT07681895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07681895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acupoint Sensitization in Inflammatory Bowel Disease: A Non-interventional Study
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
November 30, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease (ibd)